QUINCY BIOSCIENCE: PREVAGEN AND PIONEERING WITH NATURE-INSPIRED INNOVATION

Quincy Bioscience,headquartered in Middleton, Wisconsin, has been recognized as the BestBiotechnology Firm of the Year – 2025 in the United States at the prestigious Global Health & Wellness Awards. This accolade celebrates the company’s leadership in developing novel solutions for your brain, solidifying its standing as a trailblazer in the biotech sector.

The company’s core mission is the discovery, development,and commercialization of innovative technologies.. Quincy Bioscience’s scientific journey began in 2004 within the University Research Park inMadison, Wisconsin, in partnership with neuroscience expert Dr. James R. Moyer,Jr. of the University of Wisconsin at Milwaukee. This foundational collaboration set the stage for the company’s future breakthroughs and established a strong commitment to scientific excellence.

Prevagen®: The Flagship Brain supplement

The cornerstone of Quincy Bioscience’s portfolio is Prevagen®,a dietary supplement formulated with the uniquely sourced protein apoaequorin,originally discovered in jellyfish. Unlike traditional brain supplements relying on vitamins, herbal extracts, or amino acids, Prevagen leverages insights from the natural world in its formulation.

Prevagen is the number one-selling brain supplement in the U.S.for a decade, according to Nielsen IQdata, and is available in over 60,000 stores nationwide, making it highly accessible to consumers. The product’s success is further reinforced by loyalty card data indicating that Prevagen is the most re-purchased brain supplement in the country.

A key factor in Quincy Bioscience’s reputation is its commitment to quality and safety. Apoaequorin is manufactured in a cGMP compliant facility.  The company also adheres strictly to industry standards and is certified by NSF International for its quality control and manufacturing practices.

Science-Driven and Transparent Approach

Quincy Bioscience invests heavily in research and transparency. Their breakthrough ingredient, apoaequorin, has been the subject of clinical research. Research on apoaequorin, which has been ongoing since 2004, has been published in peer-reviewed journals and presented at key international neuroscience conferences, further contributing to scientific discourse and public trust.

It is essential to emphasize that Prevagen is a dietary supplement not intended to treat, cure, or prevent any disease, in accordance with FDA regulations and Quincy Bioscience’s commitment to responsible communication.

Nature-Inspired Innovation

Quincy Bioscience exemplifies the concept that many breakthroughs in biotechnology can be inspired by natural processes. By identifying and repurposing a bioluminescent protein from jellyfish—originally a NobelPrize-winning scientific discovery in the study of calcium signaling—QuincyBioscience demonstrates the power of translating biological insights into consumer products. The company’s ongoing efforts aim to inspire the broader biotech community to look to nature for novel, inherently safe mechanisms and molecules adaptable for commercial uses.

Commitment to People and Quality

Quincy Bioscience attributes its ongoing success to the dedication and expertise of its multidisciplinary team. Quality, customer care, and the drive to create products that make a positive impact are core values at every level of the organization.

Looking Forward

As Quincy Bioscience celebrates global recognition, the company remains focused on leading innovation in the biotech space. Its journey from academic partnership to market leadership illustrates how scientific curiosity can result in both commercial and societal impact. Quincy Bioscience continues to advance its mission by merging science, safety, and the wisdom of nature.

For more information:
Website: www.quincybioscience.com
Prevagen: www.prevagen.com
Phone: (608) 827-8000
Facebook: /prevagen
Instagram: @prevagen
YouTube: Prevagen Supplement

‍